APA (7th ed.) Citation

Kolbin, A. S., Kurylev, A. A., Mishinova, S. A., Balykina, Y. E., & Proskurin, M. A. (2020). Health-economic analysis of tocilizumab in patients with rheumatoid arthritis and systemic juvenile arthritis. Качественная клиническая практика, 1, 23. https://doi.org/10.37489/2588-0519-2020-1-23-33

Chicago Style (17th ed.) Citation

Kolbin, A. S., A. A. Kurylev, S. A. Mishinova, Yu. E. Balykina, and M. A. Proskurin. "Health-economic Analysis of Tocilizumab in Patients with Rheumatoid Arthritis and Systemic Juvenile Arthritis." Качественная клиническая практика 1 (2020): 23. https://doi.org/10.37489/2588-0519-2020-1-23-33.

MLA (9th ed.) Citation

Kolbin, A. S., et al. "Health-economic Analysis of Tocilizumab in Patients with Rheumatoid Arthritis and Systemic Juvenile Arthritis." Качественная клиническая практика, 1, 2020, p. 23, https://doi.org/10.37489/2588-0519-2020-1-23-33.